Check out our latest podcast episode on Rare Earth Minerals. Watch now!
Sales & Support: +1 800 762 3361
Member Resources

The U.S. government has chosen three vaccine candidates to fund Phase 3 trials under Operation Warp Speed: Moderna's mRNA-1273, the University of Oxford and AstraZeneca's AZD1222, and Pfizer and BioNTech's BNT162. For any of these vaccines to be feasible in "Warp Speed" time, technology transfer (moving the knowledge about and the ability to produce a vaccine from development to manufacturing) has to be carefully and accurately expedited.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

IIR Logo Globe

Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.

×
×

Contact Us

For More Info!